id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-0795-0009,FDA,FDA-2023-N-0795,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising,Notice,Notice of Approval,2024-07-23T04:00:00Z,2024,7,,,2024-07-23T13:27:31Z,2024-16096,0,0,09000064866021e5
FDA-2023-N-0795-0007,FDA,FDA-2023-N-0795,"Agency Information Collection Activities; Submission for Office of Management and Budget Review;
Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising",Notice,30 Day Proposed Information Collection,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,2024-01-18T04:59:59Z,2024-01-17T02:00:34Z,2023-27652,0,0,090000648634394b
FDA-2023-N-0795-0004,FDA,FDA-2023-N-0795,Reference 7 - Shengchao-s12874-017-0353-1 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising,Supporting & Related Material,Background Material,2023-04-26T04:00:00Z,2023,4,,,2023-04-26T19:38:32Z,,0,0,090000648598ca75
FDA-2023-N-0795-0002,FDA,FDA-2023-N-0795,Reference 1 - Sullivan - nihms-819225 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising,Supporting & Related Material,Background Material,2023-04-26T04:00:00Z,2023,4,,,2023-04-26T19:38:16Z,,0,0,090000648598ca72
FDA-2023-N-0795-0003,FDA,FDA-2023-N-0795,Reference 3 - Cheung - s12874-019-0786-9 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising,Supporting & Related Material,Background Material,2023-04-26T04:00:00Z,2023,4,,,2023-04-26T19:38:26Z,,0,0,090000648598ca73
FDA-2023-N-0795-0001,FDA,FDA-2023-N-0795,Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising,Notice,60 Day Proposed Information Collection,2023-04-25T04:00:00Z,2023,4,2023-04-25T04:00:00Z,2023-06-27T03:59:59Z,2023-11-01T16:56:16Z,2023-08686,0,0,09000064859844b2